GlassScriptPhysician profile
Steve O'Donnell
NPI 1326482043
$1,435.22
in general payments reported to CMS, 2019-2025
17 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $73.91 · 2023: $310 · 2024: $641 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $335.58 | 2022-2025 | |
| Lilly USA, LLC | $215.52 | 2024-2025 | Kisunla |
| Ucb, INC. | $159.11 | 2024-2025 | Rystiggo, Briviact |
| Teva Pharmaceuticals USA, INC. | $126.47 | 2023-2025 | Ajovy, Austedo Xr |
| Neurelis, INC. | $84.53 | 2023-2025 | Valtoco |
| Sk Life Science, INC. | $80.41 | 2023-2025 | |
| Lundbeck LLC | $67.60 | 2024 | Vyepti |
| Acadia Pharmaceuticals INC | $54.94 | 2024 | Nuplazid |
| Argenx US, INC. | $53.86 | 2023-2024 | Vyvgart Hytrulo |
| Alnylam Pharmaceuticals INC. | $51.00 | 2024 | Onpattro |
| Impel Pharmaceuticals INC. | $47.50 | 2022-2023 | Trudhesa |
| Csl Behring | $31.94 | 2025 | Hizentra |
| Acorda Therapeutics, INC | $29.09 | 2023 | Inbrija, Ampyra |
| Biogen, INC. | $28.74 | 2024 | Vumerity |
| Ipsen Biopharmaceuticals, INC | $27.79 | 2024 | Dysport |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $24.44 | 2024 | |
| Boston Scientific Corporation | $16.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve O'Donnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.